Lantern Pharma Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | — | $-0.28 | — | Miss |
| Q12026 FY2026 | $-0.36 | $-0.30 | +16.7% | Beat |
| Q42025 FY2025 | — | $-0.36 | — | Miss |
Back to LTRN overview · LTRN holders · LTRN KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.